Global Immuno-Oncology Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

Immuno-oncology describes the process of harnessing a patient's own immune system to fight cancer. Over the past decade, immuno-oncology has become an exciting cancer treatment approach due to its specificity, adaptability, and durability. Immuno-oncology services provide a one-stop platform to accelerate immuno-oncology research, including target selection, clinical trials, and monitoring and evaluation services.

According to our (Global Info Research) latest study, the global Immuno-Oncology Service market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Immuno-Oncology Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Immuno-Oncology Service market size and forecasts, in consumption value ($ Million), 2019-2030
Global Immuno-Oncology Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Immuno-Oncology Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Immuno-Oncology Service market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immuno-Oncology Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immuno-Oncology Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Crown Bioscience, Bio-Techne, Abcam, WuXi AppTec, Shanghai ChemPartner, George Clinical, Laboratory Corporation of America® Holdings, Medpace, Genscript, Shanghai Novamab Biopharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Immuno-Oncology Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Immuno-Oncology Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Basic Research
    Clinical Research

Market segment by Application
    Pharmaceutical Companies
    Medical Device Companies
    Other

Market segment by players, this report covers
    Crown Bioscience
    Bio-Techne
    Abcam
    WuXi AppTec
    Shanghai ChemPartner
    George Clinical
    Laboratory Corporation of America® Holdings
    Medpace
    Genscript
    Shanghai Novamab Biopharmaceuticals
    LIDE
    TransCure bioServices

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immuno-Oncology Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-Oncology Service, with revenue, gross margin, and global market share of Immuno-Oncology Service from 2019 to 2024.
Chapter 3, the Immuno-Oncology Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immuno-Oncology Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology Service.
Chapter 13, to describe Immuno-Oncology Service research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Immuno-Oncology Service by Type
        1.3.1 Overview: Global Immuno-Oncology Service Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Immuno-Oncology Service Consumption Value Market Share by Type in 2023
        1.3.3 Basic Research
        1.3.4 Clinical Research
    1.4 Global Immuno-Oncology Service Market by Application
        1.4.1 Overview: Global Immuno-Oncology Service Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Pharmaceutical Companies
        1.4.3 Medical Device Companies
        1.4.4 Other
    1.5 Global Immuno-Oncology Service Market Size & Forecast
    1.6 Global Immuno-Oncology Service Market Size and Forecast by Region
        1.6.1 Global Immuno-Oncology Service Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Immuno-Oncology Service Market Size by Region, (2019-2030)
        1.6.3 North America Immuno-Oncology Service Market Size and Prospect (2019-2030)
        1.6.4 Europe Immuno-Oncology Service Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Immuno-Oncology Service Market Size and Prospect (2019-2030)
        1.6.6 South America Immuno-Oncology Service Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Immuno-Oncology Service Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Crown Bioscience
        2.1.1 Crown Bioscience Details
        2.1.2 Crown Bioscience Major Business
        2.1.3 Crown Bioscience Immuno-Oncology Service Product and Solutions
        2.1.4 Crown Bioscience Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Crown Bioscience Recent Developments and Future Plans
    2.2 Bio-Techne
        2.2.1 Bio-Techne Details
        2.2.2 Bio-Techne Major Business
        2.2.3 Bio-Techne Immuno-Oncology Service Product and Solutions
        2.2.4 Bio-Techne Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Bio-Techne Recent Developments and Future Plans
    2.3 Abcam
        2.3.1 Abcam Details
        2.3.2 Abcam Major Business
        2.3.3 Abcam Immuno-Oncology Service Product and Solutions
        2.3.4 Abcam Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Abcam Recent Developments and Future Plans
    2.4 WuXi AppTec
        2.4.1 WuXi AppTec Details
        2.4.2 WuXi AppTec Major Business
        2.4.3 WuXi AppTec Immuno-Oncology Service Product and Solutions
        2.4.4 WuXi AppTec Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 WuXi AppTec Recent Developments and Future Plans
    2.5 Shanghai ChemPartner
        2.5.1 Shanghai ChemPartner Details
        2.5.2 Shanghai ChemPartner Major Business
        2.5.3 Shanghai ChemPartner Immuno-Oncology Service Product and Solutions
        2.5.4 Shanghai ChemPartner Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Shanghai ChemPartner Recent Developments and Future Plans
    2.6 George Clinical
        2.6.1 George Clinical Details
        2.6.2 George Clinical Major Business
        2.6.3 George Clinical Immuno-Oncology Service Product and Solutions
        2.6.4 George Clinical Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 George Clinical Recent Developments and Future Plans
    2.7 Laboratory Corporation of America® Holdings
        2.7.1 Laboratory Corporation of America® Holdings Details
        2.7.2 Laboratory Corporation of America® Holdings Major Business
        2.7.3 Laboratory Corporation of America® Holdings Immuno-Oncology Service Product and Solutions
        2.7.4 Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Laboratory Corporation of America® Holdings Recent Developments and Future Plans
    2.8 Medpace
        2.8.1 Medpace Details
        2.8.2 Medpace Major Business
        2.8.3 Medpace Immuno-Oncology Service Product and Solutions
        2.8.4 Medpace Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Medpace Recent Developments and Future Plans
    2.9 Genscript
        2.9.1 Genscript Details
        2.9.2 Genscript Major Business
        2.9.3 Genscript Immuno-Oncology Service Product and Solutions
        2.9.4 Genscript Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Genscript Recent Developments and Future Plans
    2.10 Shanghai Novamab Biopharmaceuticals
        2.10.1 Shanghai Novamab Biopharmaceuticals Details
        2.10.2 Shanghai Novamab Biopharmaceuticals Major Business
        2.10.3 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product and Solutions
        2.10.4 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Shanghai Novamab Biopharmaceuticals Recent Developments and Future Plans
    2.11 LIDE
        2.11.1 LIDE Details
        2.11.2 LIDE Major Business
        2.11.3 LIDE Immuno-Oncology Service Product and Solutions
        2.11.4 LIDE Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 LIDE Recent Developments and Future Plans
    2.12 TransCure bioServices
        2.12.1 TransCure bioServices Details
        2.12.2 TransCure bioServices Major Business
        2.12.3 TransCure bioServices Immuno-Oncology Service Product and Solutions
        2.12.4 TransCure bioServices Immuno-Oncology Service Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 TransCure bioServices Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Immuno-Oncology Service Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Immuno-Oncology Service by Company Revenue
        3.2.2 Top 3 Immuno-Oncology Service Players Market Share in 2023
        3.2.3 Top 6 Immuno-Oncology Service Players Market Share in 2023
    3.3 Immuno-Oncology Service Market: Overall Company Footprint Analysis
        3.3.1 Immuno-Oncology Service Market: Region Footprint
        3.3.2 Immuno-Oncology Service Market: Company Product Type Footprint
        3.3.3 Immuno-Oncology Service Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Immuno-Oncology Service Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Immuno-Oncology Service Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Immuno-Oncology Service Consumption Value Market Share by Application (2019-2024)
    5.2 Global Immuno-Oncology Service Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Immuno-Oncology Service Consumption Value by Type (2019-2030)
    6.2 North America Immuno-Oncology Service Market Size by Application (2019-2030)
    6.3 North America Immuno-Oncology Service Market Size by Country
        6.3.1 North America Immuno-Oncology Service Consumption Value by Country (2019-2030)
        6.3.2 United States Immuno-Oncology Service Market Size and Forecast (2019-2030)
        6.3.3 Canada Immuno-Oncology Service Market Size and Forecast (2019-2030)
        6.3.4 Mexico Immuno-Oncology Service Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Immuno-Oncology Service Consumption Value by Type (2019-2030)
    7.2 Europe Immuno-Oncology Service Consumption Value by Application (2019-2030)
    7.3 Europe Immuno-Oncology Service Market Size by Country
        7.3.1 Europe Immuno-Oncology Service Consumption Value by Country (2019-2030)
        7.3.2 Germany Immuno-Oncology Service Market Size and Forecast (2019-2030)
        7.3.3 France Immuno-Oncology Service Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Immuno-Oncology Service Market Size and Forecast (2019-2030)
        7.3.5 Russia Immuno-Oncology Service Market Size and Forecast (2019-2030)
        7.3.6 Italy Immuno-Oncology Service Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Immuno-Oncology Service Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Immuno-Oncology Service Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Immuno-Oncology Service Market Size by Region
        8.3.1 Asia-Pacific Immuno-Oncology Service Consumption Value by Region (2019-2030)
        8.3.2 China Immuno-Oncology Service Market Size and Forecast (2019-2030)
        8.3.3 Japan Immuno-Oncology Service Market Size and Forecast (2019-2030)
        8.3.4 South Korea Immuno-Oncology Service Market Size and Forecast (2019-2030)
        8.3.5 India Immuno-Oncology Service Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Immuno-Oncology Service Market Size and Forecast (2019-2030)
        8.3.7 Australia Immuno-Oncology Service Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Immuno-Oncology Service Consumption Value by Type (2019-2030)
    9.2 South America Immuno-Oncology Service Consumption Value by Application (2019-2030)
    9.3 South America Immuno-Oncology Service Market Size by Country
        9.3.1 South America Immuno-Oncology Service Consumption Value by Country (2019-2030)
        9.3.2 Brazil Immuno-Oncology Service Market Size and Forecast (2019-2030)
        9.3.3 Argentina Immuno-Oncology Service Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Immuno-Oncology Service Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Immuno-Oncology Service Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Immuno-Oncology Service Market Size by Country
        10.3.1 Middle East & Africa Immuno-Oncology Service Consumption Value by Country (2019-2030)
        10.3.2 Turkey Immuno-Oncology Service Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Immuno-Oncology Service Market Size and Forecast (2019-2030)
        10.3.4 UAE Immuno-Oncology Service Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Immuno-Oncology Service Market Drivers
    11.2 Immuno-Oncology Service Market Restraints
    11.3 Immuno-Oncology Service Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Immuno-Oncology Service Industry Chain
    12.2 Immuno-Oncology Service Upstream Analysis
    12.3 Immuno-Oncology Service Midstream Analysis
    12.4 Immuno-Oncology Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Immuno-Oncology Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Immuno-Oncology Service Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Immuno-Oncology Service Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Immuno-Oncology Service Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Crown Bioscience Company Information, Head Office, and Major Competitors
 Table 6. Crown Bioscience Major Business
 Table 7. Crown Bioscience Immuno-Oncology Service Product and Solutions
 Table 8. Crown Bioscience Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Crown Bioscience Recent Developments and Future Plans
 Table 10. Bio-Techne Company Information, Head Office, and Major Competitors
 Table 11. Bio-Techne Major Business
 Table 12. Bio-Techne Immuno-Oncology Service Product and Solutions
 Table 13. Bio-Techne Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Bio-Techne Recent Developments and Future Plans
 Table 15. Abcam Company Information, Head Office, and Major Competitors
 Table 16. Abcam Major Business
 Table 17. Abcam Immuno-Oncology Service Product and Solutions
 Table 18. Abcam Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. WuXi AppTec Company Information, Head Office, and Major Competitors
 Table 20. WuXi AppTec Major Business
 Table 21. WuXi AppTec Immuno-Oncology Service Product and Solutions
 Table 22. WuXi AppTec Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. WuXi AppTec Recent Developments and Future Plans
 Table 24. Shanghai ChemPartner Company Information, Head Office, and Major Competitors
 Table 25. Shanghai ChemPartner Major Business
 Table 26. Shanghai ChemPartner Immuno-Oncology Service Product and Solutions
 Table 27. Shanghai ChemPartner Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Shanghai ChemPartner Recent Developments and Future Plans
 Table 29. George Clinical Company Information, Head Office, and Major Competitors
 Table 30. George Clinical Major Business
 Table 31. George Clinical Immuno-Oncology Service Product and Solutions
 Table 32. George Clinical Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. George Clinical Recent Developments and Future Plans
 Table 34. Laboratory Corporation of America® Holdings Company Information, Head Office, and Major Competitors
 Table 35. Laboratory Corporation of America® Holdings Major Business
 Table 36. Laboratory Corporation of America® Holdings Immuno-Oncology Service Product and Solutions
 Table 37. Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. Laboratory Corporation of America® Holdings Recent Developments and Future Plans
 Table 39. Medpace Company Information, Head Office, and Major Competitors
 Table 40. Medpace Major Business
 Table 41. Medpace Immuno-Oncology Service Product and Solutions
 Table 42. Medpace Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. Medpace Recent Developments and Future Plans
 Table 44. Genscript Company Information, Head Office, and Major Competitors
 Table 45. Genscript Major Business
 Table 46. Genscript Immuno-Oncology Service Product and Solutions
 Table 47. Genscript Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. Genscript Recent Developments and Future Plans
 Table 49. Shanghai Novamab Biopharmaceuticals Company Information, Head Office, and Major Competitors
 Table 50. Shanghai Novamab Biopharmaceuticals Major Business
 Table 51. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product and Solutions
 Table 52. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 53. Shanghai Novamab Biopharmaceuticals Recent Developments and Future Plans
 Table 54. LIDE Company Information, Head Office, and Major Competitors
 Table 55. LIDE Major Business
 Table 56. LIDE Immuno-Oncology Service Product and Solutions
 Table 57. LIDE Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 58. LIDE Recent Developments and Future Plans
 Table 59. TransCure bioServices Company Information, Head Office, and Major Competitors
 Table 60. TransCure bioServices Major Business
 Table 61. TransCure bioServices Immuno-Oncology Service Product and Solutions
 Table 62. TransCure bioServices Immuno-Oncology Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 63. TransCure bioServices Recent Developments and Future Plans
 Table 64. Global Immuno-Oncology Service Revenue (USD Million) by Players (2019-2024)
 Table 65. Global Immuno-Oncology Service Revenue Share by Players (2019-2024)
 Table 66. Breakdown of Immuno-Oncology Service by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 67. Market Position of Players in Immuno-Oncology Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 68. Head Office of Key Immuno-Oncology Service Players
 Table 69. Immuno-Oncology Service Market: Company Product Type Footprint
 Table 70. Immuno-Oncology Service Market: Company Product Application Footprint
 Table 71. Immuno-Oncology Service New Market Entrants and Barriers to Market Entry
 Table 72. Immuno-Oncology Service Mergers, Acquisition, Agreements, and Collaborations
 Table 73. Global Immuno-Oncology Service Consumption Value (USD Million) by Type (2019-2024)
 Table 74. Global Immuno-Oncology Service Consumption Value Share by Type (2019-2024)
 Table 75. Global Immuno-Oncology Service Consumption Value Forecast by Type (2025-2030)
 Table 76. Global Immuno-Oncology Service Consumption Value by Application (2019-2024)
 Table 77. Global Immuno-Oncology Service Consumption Value Forecast by Application (2025-2030)
 Table 78. North America Immuno-Oncology Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 79. North America Immuno-Oncology Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 80. North America Immuno-Oncology Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 81. North America Immuno-Oncology Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 82. North America Immuno-Oncology Service Consumption Value by Country (2019-2024) & (USD Million)
 Table 83. North America Immuno-Oncology Service Consumption Value by Country (2025-2030) & (USD Million)
 Table 84. Europe Immuno-Oncology Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 85. Europe Immuno-Oncology Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 86. Europe Immuno-Oncology Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 87. Europe Immuno-Oncology Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 88. Europe Immuno-Oncology Service Consumption Value by Country (2019-2024) & (USD Million)
 Table 89. Europe Immuno-Oncology Service Consumption Value by Country (2025-2030) & (USD Million)
 Table 90. Asia-Pacific Immuno-Oncology Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 91. Asia-Pacific Immuno-Oncology Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 92. Asia-Pacific Immuno-Oncology Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 93. Asia-Pacific Immuno-Oncology Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 94. Asia-Pacific Immuno-Oncology Service Consumption Value by Region (2019-2024) & (USD Million)
 Table 95. Asia-Pacific Immuno-Oncology Service Consumption Value by Region (2025-2030) & (USD Million)
 Table 96. South America Immuno-Oncology Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 97. South America Immuno-Oncology Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 98. South America Immuno-Oncology Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 99. South America Immuno-Oncology Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 100. South America Immuno-Oncology Service Consumption Value by Country (2019-2024) & (USD Million)
 Table 101. South America Immuno-Oncology Service Consumption Value by Country (2025-2030) & (USD Million)
 Table 102. Middle East & Africa Immuno-Oncology Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 103. Middle East & Africa Immuno-Oncology Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 104. Middle East & Africa Immuno-Oncology Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 105. Middle East & Africa Immuno-Oncology Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 106. Middle East & Africa Immuno-Oncology Service Consumption Value by Country (2019-2024) & (USD Million)
 Table 107. Middle East & Africa Immuno-Oncology Service Consumption Value by Country (2025-2030) & (USD Million)
 Table 108. Global Key Players of Immuno-Oncology Service Upstream (Raw Materials)
 Table 109. Global Immuno-Oncology Service Typical Customers


List of Figures
 Figure 1. Immuno-Oncology Service Picture
 Figure 2. Global Immuno-Oncology Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Immuno-Oncology Service Consumption Value Market Share by Type in 2023
 Figure 4. Basic Research
 Figure 5. Clinical Research
 Figure 6. Global Immuno-Oncology Service Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Immuno-Oncology Service Consumption Value Market Share by Application in 2023
 Figure 8. Pharmaceutical Companies Picture
 Figure 9. Medical Device Companies Picture
 Figure 10. Other Picture
 Figure 11. Global Immuno-Oncology Service Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Immuno-Oncology Service Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Market Immuno-Oncology Service Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 14. Global Immuno-Oncology Service Consumption Value Market Share by Region (2019-2030)
 Figure 15. Global Immuno-Oncology Service Consumption Value Market Share by Region in 2023
 Figure 16. North America Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 17. Europe Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 18. Asia-Pacific Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 19. South America Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 20. Middle East & Africa Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 21. Company Three Recent Developments and Future Plans
 Figure 22. Global Immuno-Oncology Service Revenue Share by Players in 2023
 Figure 23. Immuno-Oncology Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 24. Market Share of Immuno-Oncology Service by Player Revenue in 2023
 Figure 25. Top 3 Immuno-Oncology Service Players Market Share in 2023
 Figure 26. Top 6 Immuno-Oncology Service Players Market Share in 2023
 Figure 27. Global Immuno-Oncology Service Consumption Value Share by Type (2019-2024)
 Figure 28. Global Immuno-Oncology Service Market Share Forecast by Type (2025-2030)
 Figure 29. Global Immuno-Oncology Service Consumption Value Share by Application (2019-2024)
 Figure 30. Global Immuno-Oncology Service Market Share Forecast by Application (2025-2030)
 Figure 31. North America Immuno-Oncology Service Consumption Value Market Share by Type (2019-2030)
 Figure 32. North America Immuno-Oncology Service Consumption Value Market Share by Application (2019-2030)
 Figure 33. North America Immuno-Oncology Service Consumption Value Market Share by Country (2019-2030)
 Figure 34. United States Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 35. Canada Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 36. Mexico Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 37. Europe Immuno-Oncology Service Consumption Value Market Share by Type (2019-2030)
 Figure 38. Europe Immuno-Oncology Service Consumption Value Market Share by Application (2019-2030)
 Figure 39. Europe Immuno-Oncology Service Consumption Value Market Share by Country (2019-2030)
 Figure 40. Germany Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 41. France Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 42. United Kingdom Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 43. Russia Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 44. Italy Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 45. Asia-Pacific Immuno-Oncology Service Consumption Value Market Share by Type (2019-2030)
 Figure 46. Asia-Pacific Immuno-Oncology Service Consumption Value Market Share by Application (2019-2030)
 Figure 47. Asia-Pacific Immuno-Oncology Service Consumption Value Market Share by Region (2019-2030)
 Figure 48. China Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 49. Japan Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 50. South Korea Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 51. India Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 52. Southeast Asia Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 53. Australia Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 54. South America Immuno-Oncology Service Consumption Value Market Share by Type (2019-2030)
 Figure 55. South America Immuno-Oncology Service Consumption Value Market Share by Application (2019-2030)
 Figure 56. South America Immuno-Oncology Service Consumption Value Market Share by Country (2019-2030)
 Figure 57. Brazil Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 58. Argentina Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 59. Middle East & Africa Immuno-Oncology Service Consumption Value Market Share by Type (2019-2030)
 Figure 60. Middle East & Africa Immuno-Oncology Service Consumption Value Market Share by Application (2019-2030)
 Figure 61. Middle East & Africa Immuno-Oncology Service Consumption Value Market Share by Country (2019-2030)
 Figure 62. Turkey Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 63. Saudi Arabia Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 64. UAE Immuno-Oncology Service Consumption Value (2019-2030) & (USD Million)
 Figure 65. Immuno-Oncology Service Market Drivers
 Figure 66. Immuno-Oncology Service Market Restraints
 Figure 67. Immuno-Oncology Service Market Trends
 Figure 68. Porters Five Forces Analysis
 Figure 69. Immuno-Oncology Service Industrial Chain
 Figure 70. Methodology
 Figure 71. Research Process and Data Source

Companies Mentioned

Crown Bioscience
Bio-Techne
Abcam
WuXi AppTec
Shanghai ChemPartner
George Clinical
Laboratory Corporation of America® Holdings
Medpace
Genscript
Shanghai Novamab Biopharmaceuticals
LIDE
TransCure bioServices